Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4

Background The efficacy of checkpoint blockade immunotherapies in colorectal cancer is currently restricted to a minority of patients diagnosed with mismatch repair-deficient tumors having high mutation burden. However, this observation does not exclude the existence of neoantigen-specific T cells i...

Full description

Saved in:
Bibliographic Details
Published in:Genome medicine Vol. 11; no. 1; pp. 87 - 15
Main Authors: van den Bulk, Jitske, Verdegaal, Els M. E., Ruano, Dina, Ijsselsteijn, Marieke E., Visser, Marten, van der Breggen, Ruud, Duhen, Thomas, van der Ploeg, Manon, de Vries, Natasja L., Oosting, Jan, Peeters, Koen C. M. J., Weinberg, Andrew D., Farina-Sarasqueta, Arantza, van der Burg, Sjoerd H., de Miranda, Noel F. C. C.
Format: Journal Article
Language:English
Published: London BioMed Central 30.12.2019
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
DNA
CMS
ISSN:1756-994X, 1756-994X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first